Explore related pages
Related company profiles:
News
Digital Transformation and Artificial Intelligence - Sanofi
Digital Transformation and Artificial Intelligence Sanofi
Sanofi: Information concerning the total number of voting rights and shares - July 2025 - GlobeNewswire
Sanofi: Information concerning the total number of voting rights and shares - July 2025 GlobeNewswire
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation - Yahoo Finance
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation Yahoo Finance
Our Responsible Business Values & Ethics - Sanofi
Our Responsible Business Values & Ethics Sanofi
Press release: Online availability of Sanofi’s half-year financial report for 2025 - GlobeNewswire
Press release: Online availability of Sanofi’s half-year financial report for 2025 GlobeNewswire
Press Release: Sanofi announces extension of Blueprint tender offer - Yahoo Finance
Press Release: Sanofi announces extension of Blueprint tender offer Yahoo Finance
Respiratory Syncytial Virus (RSV) - Sanofi
Respiratory Syncytial Virus (RSV) Sanofi
Press release: Availability of the Q3 2025 Aide mémoire - GlobeNewswire
Press release: Availability of the Q3 2025 Aide mémoire GlobeNewswire
Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 - Yahoo Finance
Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 Yahoo Finance
Environmental Impact and Healthcare Systems’ Resilience - Sanofi
Environmental Impact and Healthcare Systems’ Resilience Sanofi
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. - GlobeNewswire
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. GlobeNewswire
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease - Yahoo Finance
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Yahoo Finance
Sustainability: Building a Healthier World - Sanofi
Sustainability: Building a Healthier World Sanofi
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia - GlobeNewswire
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia GlobeNewswire
Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis - Yahoo Finance
Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Yahoo Finance
Global Health Unit: Expanding Healthcare Access - Sanofi
Global Health Unit: Expanding Healthcare Access Sanofi
Our DE&I Board: Leading Diversity - Sanofi
Our DE&I Board: Leading Diversity Sanofi
Press release: Sanofi successfully prices €1.5 billion bond issue - GlobeNewswire
Press release: Sanofi successfully prices €1.5 billion bond issue GlobeNewswire
Information on Dengvaxia® (Dengue tetravalent vaccine) - Sanofi
Information on Dengvaxia® (Dengue tetravalent vaccine) Sanofi
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season - Yahoo Finance
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Yahoo Finance
Press Release: Sanofi completes acquisition of DR-0201 - GlobeNewswire
Press Release: Sanofi completes acquisition of DR-0201 GlobeNewswire
Press Release: Sanofi to acquire Blueprint Medicines, - GlobeNewswire
Press Release: Sanofi to acquire Blueprint Medicines, GlobeNewswire
Our Global Manufacturing & Supply Network - Sanofi
Our Global Manufacturing & Supply Network Sanofi
Our Science - Sanofi
Our Science Sanofi
Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US - Yahoo Finance
Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US Yahoo Finance
Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease - Yahoo Finance
Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease Yahoo Finance
Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose - Yahoo Finance
Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose Yahoo Finance
A Legacy of Impact - Sanofi
A Legacy of Impact Sanofi
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study - Yahoo Finance
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study Yahoo Finance
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia - Yahoo Finance
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Yahoo Finance
Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts - Yahoo Finance
Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts Yahoo Finance
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion - Yahoo Finance
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion Yahoo Finance
Press Release: Sanofi’s SAR402663 earns fast track - GlobeNewswire
Press Release: Sanofi’s SAR402663 earns fast track GlobeNewswire
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline - GlobeNewswire
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline GlobeNewswire
Share, Structure and Voting Rights - Sanofi
Share, Structure and Voting Rights Sanofi
Press Release: Sanofi completes acquisition of Blueprint Medicines - GlobeNewswire
Press Release: Sanofi completes acquisition of Blueprint Medicines GlobeNewswire
Press Release: Sanofi’s SAR446597 earns fast track - GlobeNewswire
Press Release: Sanofi’s SAR446597 earns fast track GlobeNewswire
Press Release: Opella reaches study milestone for Cialis - Yahoo Finance
Press Release: Opella reaches study milestone for Cialis Yahoo Finance
Press Release: Sanofi’s Sarclisa approved in the EU for the - GlobeNewswire
Press Release: Sanofi’s Sarclisa approved in the EU for the GlobeNewswire
mRNA Technology: Vaccines and Beyond - Sanofi
mRNA Technology: Vaccines and Beyond Sanofi
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader - GlobeNewswire
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader GlobeNewswire
Press Release: Sanofi to acquire Dren Bio’s bispecific - GlobeNewswire
Press Release: Sanofi to acquire Dren Bio’s bispecific GlobeNewswire
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., - GlobeNewswire
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., GlobeNewswire
Sanofi's New $1M Community Health Fund Targets 14 Mass. Organizations to Transform Healthcare Access - Stock Titan
Sanofi's New $1M Community Health Fund Targets 14 Mass. Organizations to Transform Healthcare Access Stock Titan
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare - GlobeNewswire
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare GlobeNewswire
Press Release: Sanofi’s respiratory pipeline advances with - GlobeNewswire
Press Release: Sanofi’s respiratory pipeline advances with GlobeNewswire
Interested in partnering with Sanofi Pasteur? - Nature
Interested in partnering with Sanofi Pasteur? Nature
Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact - PR Newswire Canada
Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact PR Newswire Canada
Sanofi India Share Price Today - Sanofi India Stock Price Live NSE/BSE - ICICI Direct
Sanofi India Share Price Today - Sanofi India Stock Price Live NSE/BSE ICICI Direct
Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery - MultiVu
Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery MultiVu
Sanofi receives marketing approval for its diabetes drug Soliqua™ in India - Passionate In Marketing
Sanofi receives marketing approval for its diabetes drug Soliqua™ in India Passionate In Marketing
Top Sanofi India Ltd Employees
-
Santosh Khandelwal
Head - Finance Business Partner At…
Mumbai, Maharashtra, India, India2gmail.com, genzyme.com -
Umesh P
Head- Export/ Import Operations At…
Mumbai, Maharashtra, India, India -
soni SANJEEV
Public Market Business/ Market Access/…
New Delhi, Delhi, India, India2gmail.com, sanofi.com -
Kashyap Shah
Director-Taxation At Sanofi India…
Mumbai, Maharashtra, India, India3wockhardt.com, yahoo.com, sanofi.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.